Omnicell (OMCL) reiterated guidance for Q1 and FY25 after announcing that CFO Nchacha Etta will be stepping down. Omnicell ...
The chief financial officer of Omnicell plans to step down sometime this year. The maker of automated medication-management systems said Wednesday that Nchacha Etta intends to depart on Sept. 15 or ...
(NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy and nursing care delivery model, today announced that Nchacha Etta will be stepping ...
Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...
Leaders from Penn Highlands Healthcare joined members of the Greater DuBois Chamber of Commerce this week to cut the ribbon ...
The global Pharmacy Automation Market, valued at US$6.23 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching US$6.65 billion ...
The global Pharmacy Automation Market, valued at US$6.23 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, ...
On Wednesday, leaders from Penn Highlands Healthcare joined members of the Greater DuBois Chamber of Commerce to cut the ...
OMCL's shares rise on the back of its XT Amplify program gaining market acceptance with its offerings. However, the unfavorable macroeconomic scenario is concerning.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BeiGene (ONC – Research Report) and Omnicell (OMCL – Research Report). See what stocks are ...
There are statutory and professional obligations relating to medicine safety: Practices should consider informing all patients about the importance of telling their clinicians about any prescribed and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results